Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 11This work was supported by a grant from Bristol-Myers Squibb, Princeton, New Jersey.-Reference-Cited by-同舟云学术

Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 11This work was supported by a grant from Bristol-Myers Squibb, Princeton, New Jersey.

Published:1998-04 Issue:7 Volume:81 Page:869-876
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Pratt Craig M.,Camm A.John,Cooper William,Friedman Peter L.,MacNeil Daniel J.,Moulton Kathleen M.,Pitt Bertram,Schwartz Peter J.,Veltri Enrico P.,Waldo Albert L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Ventricular premature complexes and sudden death after myocardial infarction;Ruberman;Circulation,1981

2. Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction;Moss;Circulation,1979

3. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction;Bigger;Circulation,1984

4. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after myocardial infarction;Am J Cardiol,1988

5. Clinical classification of cardiac deaths;Hinkle;Circulation,1982

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current State of Realistic Heart Models for Disease Modelling and Cardiotoxicity;International Journal of Molecular Sciences;2024-08-24

2. Atrial fibrillation: better symptom control with rate and rhythm management;The Lancet Regional Health - Europe;2024-02

3. Multifactorial approaches to enhance maturation of human iPSC-derived cardiomyocytes;Journal of Molecular Liquids;2023-10

4. Sex Differences in High-Cost Users for Atrial Fibrillation;CJC Open;2023-10

5. Modeling Stereospecific Drug Interactions with Beta-Adrenergic Receptors;2023-10-01